ALEXANDRIA, Va., March 12 -- United States Patent no. 12,246,023, issued on March 11, was assigned to AXSOME THERAPEUTICS INC. (New York).
"Use of reboxetine to treat narcolepsy" was invented by Herriot Tabuteau (New York).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are methods of treating narcolepsy with cataplexy, comprising administering reboxetine to a human being in need thereof. Reboxetine may also be used in the manufacture of a medicament for the treatment of narcolepsy with cataplexy. Also disclosed herein are kits comprising a pharmaceutical composition comprising reboxetine and instructions to use the pharmaceutical composition to treat narcolepsy with cataplexy in a human being...